MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells
Purpose. Dendritic cells (DC) are specialized antigen-presenting cells, and cytokine-induced killer (CIK) cells have a specific killing activity to a variety of tumors. However, the underlining mechanism and function of DC-CIK cells in acute myeloid leukemia (AML) remain largely elusive. Methods. Ge...
Saved in:
Main Authors: | Min Dong, Guozhen Zhang, Jie Meng, Biou Liu, Duanfeng Jiang, Feng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2023/2490943 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stimulation of MMP-1 and CCL2 by NAMPT in PDL Cells
by: Marjan Nokhbehsaim, et al.
Published: (2013-01-01) -
The Therapeutic Effect of Cytokine-Induced Killer Cells on Pancreatic Cancer Enhanced by Dendritic Cells Pulsed with K-Ras Mutant Peptide
by: Guang Tan, et al.
Published: (2011-01-01) -
Bone marrow immune cells and drug resistance in acute myeloid leukemia
by: Miao Zhang, et al.
Published: (2025-02-01) -
Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases
by: Shih-Wen Huang, et al.
Published: (2025-01-01) -
HIFU-CCL19/21 Axis Enhances Dendritic Cell Vaccine Efficacy in the Tumor Microenvironment
by: Bum-Seo Baek, et al.
Published: (2025-01-01)